作者
Francesco Locatelli, Peter Bárány, Adrian Covic, Angel De Francisco, Lucia Del Vecchio, David Goldsmith, Walter Hörl, Gerard London, Raymond Vanholder, Wim Van Biesen, Era-Edta Erbp Advisory Board, D Abramovicz, J Cannata-Andia, P Cochat, KU Eckardt, D Fouque, O Heimburger, K Jäger, S Jenkins, E Lindley, A MacLeod, A Marti-Monros, J Tattersall, A Wiecek, C Wanner
发表日期
2013/6/1
期刊
Nephrology Dialysis Transplantation
卷号
28
期号
6
页码范围
1346-1359
出版商
Oxford University Press
简介
Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) group has produced comprehensive clinical practice guidelines for the management of anaemia in CKD patients. These guidelines addressed all of the important points related to anaemia management in CKD patients, including therapy with erythropoieis stimulating agents (ESA), iron therapy, ESA resistance and blood transfusion use. Because most guidelines were ‘soft’ rather than ‘strong’, and because global guidelines need to be adapted and implemented into the regional context where they are used, on behalf of the European Renal Best Practice Advisory Board some of its members, and other external experts in this field, who were not participants in the KDIGO guidelines group, were invited to participate in this anaemia working group to examine and comment on the KDIGO documents in this position paper. In this article, the group …
引用总数
201320142015201620172018201920202021202220232024104744485133414351564433